Trial Profile
A Particle Size Study of 3 Different Particle Size Test Tablet Formulations Compared to the Reference Tablet Formulation in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Sep 2021
Price :
$35
*
At a glance
- Drugs Pomaglumetad methionil (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Sponsors Denovo Biopharma
- 02 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 10 May 2012 New trial record